Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Key Information
Due Date: May 7, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This is information about a funding opportunity for clinical neuroscience research on Substance Use Disorders (SUD), namely the (R61/R33 Clinical Trial Optional) Exploratory Clinical Neuroscience Research grant. The grant is offered through a Phased Innovation Award model, aimed specifically at studies that are exploratory and developmental in their nature. The research focus should be on understanding the neurobiological mechanisms that underpin SUD, and should also delve into the basics of brain function as it relates to substance use. One particular attribute of this grant is that it is designed to fund projects that need more budget than the R21 mechanism allows, which is a similar but separate funding opportunity for neuroscience research on drug abuse, also with optional clinical trials.
Show More
Key Dates
Open Date: April 10, 2023
Application Due Date: May 7, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses